Clínica Medilaser in Colombia ended 2025 with 900,000 health services provided, a 20% increase from the previous year. This growth includes new branches and awards for specialized care. The institution created over 900 additional jobs during the year.
Clínica Medilaser, headquartered in Huila, Colombia, reported significant growth in its operations during 2025. The institution provided 900,000 health services, up from 750,000 in 2024, driven by network expansion and specialization in high-complexity procedures.
Key services included 50,161 surgical procedures, an increase of over 10,000 from the previous year; 43,512 hospitalizations; 239,798 emergencies, also with more than 10,000 additional cases; 217,084 outpatient consultations, nearly 50,000 more than in 2024; 317,021 diagnostic images; 6,114 births; and over 1,430,000 lab tests processed.
By branch, the impact was regional: Neiva with 454,787 attendances; Centro, 300,167; Abner Lozano, 106,063; Materno Infantil, 48,557; Florencia, 129,289; Tunja, 159,262; and the new Facatativá branch in Cundinamarca, 86,846 attendances.
In employment terms, the clinic ended the year with over 3,600 staff, 968 of whom joined in 2025, boosting health sector jobs.
Achievements included certification as a Family-Responsible Company (EFR), international recognition for stroke (ACV) care, consolidation in high-complexity cardiovascular treatment, the first INVIMA-certified Clinical Research Center in southern Colombia, the opening of the Facatativá branch, and the Southern Oncology Route for comprehensive cancer treatment.
"The most important impact is not just in the numbers, but in what they represent: access to specialized services, diagnostic opportunities that did not exist before in the region, and comprehensive care for thousands of families," said Argenis Garavito Arévalo, Vice President of Technical and Operational Affairs.
For 2026, the institution plans to focus on clinical research, hospital infrastructure expansion, oncology and cardiovascular services, and biomedical technologies.